Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Joshua Lukenbill"'
Autor:
Lorenzo Cohen, Suzanne Danhauer, David Ira Rosenthal, Mark Steven Chambers, M. Kay Garcia, Andrew Cusimano, Mark Brown, Emily Van Meter Dressler, Jewel Ochoa, Peiying Yang, Joseph S Chiang, Ora Gordon, Rhonda Crutcher, Jung K Kim, Michael P. Russin, Joshua Lukenbill, Mercedes Porosnicu, Kathleen J Yost, Kathryn E. Weaver, Glenn Jay Lesser
Publikováno v:
Journal of Clinical Oncology. 40:12004-12004
12004 Background: The majority of head/neck (HN) patients who undergo radiotherapy develop RIX. Unfortunately, existing treatments are of limited benefit and have side effects. Initial small studies suggest acupuncture may treat chronic RIX. A multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4679ab11d250b033203c610791d01b7
https://doi.org/10.1200/jco.2022.40.16_suppl.12004
https://doi.org/10.1200/jco.2022.40.16_suppl.12004
Autor:
Lindy Gasperi, Kristi Adams, Vedica Sharma, Robert J. Schneider, Joshua Lukenbill, Matthew J Taylor, Geoffrey C. Wall
Publikováno v:
Journal of pharmacy practice. 34(4)
Background: Intravenous (IV) iron sucrose can be used for iron deficiency anemia (IDA), but little information exists on total dose infusion (TDI) of this drug. At a tertiary hospital, an iron sucrose TDI protocol was implemented with staff pharmacis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6238d8954b28060831664a3293e3b8e4
https://pubmed.ncbi.nlm.nih.gov/31665957
https://pubmed.ncbi.nlm.nih.gov/31665957
Autor:
Joshua Lukenbill, Brian T. Hill
Publikováno v:
Leukemia & Lymphoma. 56:293-300
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is difficult to treat, with limited therapeutic options. Review of prognostic indices, DLBCL genetic classification, previous rituximab exposure, interval from previous therapy, chemosensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eee30bebb6f649914028d4dedf31ff9c
https://doi.org/10.3109/10428194.2014.910660
https://doi.org/10.3109/10428194.2014.910660
Autor:
Vedica Sharma, Matthew H. Taylor, Kristi Adams, Robert J. Schneider, Geoff C. Wall, Gasperi Lindy, Joshua Lukenbill
Publikováno v:
Blood. 132:5824-5824
Introduction Iron deficiency anemia (IDA) is the leading cause of anemia in the United States. Although oral iron formulations can correct IDA, they are generally poorly tolerated due to gastrointestinal side effects and may require long term use to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba14fcbd67670638f5e9ffca361c9a2
https://doi.org/10.1182/blood-2018-99-109788
https://doi.org/10.1182/blood-2018-99-109788
Autor:
Robert Butler, Matt Kalaycio, Brian J. Bolwell, Edward A. Copelan, Steven Andresen, Robert M. Dean, Sherif B. Mossad, Brad Pohlman, Joshua Lukenbill, Ronald Sobecks
Publikováno v:
Clinical Microbiology: Open Access.
Our goal was to prospectively assess the immunological response to the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in autologous cell transplantation (AHCT) recipients using pneumococcal IgG (PNEIGG) titers. PNEIGG titers were collected pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9a7d6c0ced1ec44cb0411f1870a27d0
https://doi.org/10.4172/2327-5073.1000177
https://doi.org/10.4172/2327-5073.1000177
Autor:
Anjali S. Advani, Joshua Lukenbill
Publikováno v:
Current hematologic malignancy reports. 8(2)
Adolescents and young adult (AYA) patients with acute lymphoblastic leukemia (ALL), 16–40 years of age, were historically not the focus of prospective studies on ALL treatment. This population has unique genetic, immunophenotypic, and clinical feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0f53f8246518f74ac5b8ac404e52ed
https://pubmed.ncbi.nlm.nih.gov/23559026
https://pubmed.ncbi.nlm.nih.gov/23559026
Autor:
Joshua Lukenbill, Matt Kalaycio
Publikováno v:
Leukemia research. 37(9)
Background Fludarabine successfully treats chronic lymphocytic leukemia (CLL); however, its use may lead to significant myelosuppression and other toxicities. This article weighs the benefits against potential harms, highlighting strategies for appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe99c5e8d46e6c4b840bce25e138a638
https://pubmed.ncbi.nlm.nih.gov/23787174
https://pubmed.ncbi.nlm.nih.gov/23787174
Autor:
Mikkael A. Sekeres, Joshua Lukenbill, Paul Elson, Anjali S. Advani, Yogen Saunthararajah, Cassandra Kendeigh, Ramon V. Tiu, Sanjay R. Mohan, Matt Kalaycio, Jaroslaw P. Maciejewski, Edward A. Copelan, Leslie Farhat
Publikováno v:
Blood. 120:4321-4321
Abstract 4321 Acute myeloid leukemia (AML) may present with vascular phenomena, commonly manifested in the pulmonary and neurologic systems, and often attributed to leukostasis, thrombotic abnormalities as with acute promyelocytic leukemia (APL), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c9d3b6909b6054828fcd638c9a6448c
https://doi.org/10.1182/blood.v120.21.4321.4321
https://doi.org/10.1182/blood.v120.21.4321.4321
Autor:
Lisa Rybicki, Rabi Hanna, Megan DiGiorgio, Alexander Copelan, Brian J. Bolwell, Ronald Sobecks, Housam Haddad, Omer Zaman, Hien K. Duong, Brian T. Hill, Matt Kalaycio, Edward A. Copelan, Joshua Lukenbill, Thomas G. Fraser, Mikkael A. Sekeres
Publikováno v:
Blood. 120:4481-4481
Abstract 4481 Patients undergoing hematopoietic cell transplantation (HCT) require central venous access during treatment, predisposing this inherently susceptible population to infection. Central line-associated blood stream infection (CLABSI) is de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c8c1f832b2594955f2f719c463a5156
https://doi.org/10.1182/blood.v120.21.4481.4481
https://doi.org/10.1182/blood.v120.21.4481.4481
Autor:
Robert M. Dean, Hien K. Duong, Steven Andresen, John W. Sweetenham, Ronald Sobecks, Sherif B. Mossad, B. Bolwell, R. Butler, Brian T. Hill, Brad Pohlman, Matt Kalaycio, Edward A. Copelan, Joshua Lukenbill
Publikováno v:
Biology of Blood and Marrow Transplantation. 18:S237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0702d9cc9d853c117e9143aeb309947
https://doi.org/10.1016/j.bbmt.2011.12.099
https://doi.org/10.1016/j.bbmt.2011.12.099